Stereotaxis has received FDA's approval for its partnered magnetic irrigated catheter for use in mapping and ablation in the US.
Subscribe to our email newsletter
Bevil Hogg, CEO of Stereotaxis, said: “The Stereotaxis Magnetic Navigation System, used in conjunction with the magnetic irrigated catheter and the company’s latest software release has performed extremely well with a high degree of safety. We are confident that the Stereotaxis Magnetic Navigation System with the irrigated catheter has the potential to establish a new standard of care in the treatment of complex arrhythmias.”
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.